These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22180525)

  • 21. Antibody responses to trivalent influenza vaccine in Iranian adults infected with human immunodeficiency virus.
    Rasoolinejad M; Jafari S; Montazeri M; Mohseni M; Foroughi M; Moradmand Badie B; Saatian M; Marashi SM; Mokhtari Azad T
    Acta Med Iran; 2013 Apr; 51(3):148-52. PubMed ID: 23605597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term seroprotective response of trivalent seasonal influenza vaccine in HIV-infected children, regardless of immunogenicity before immunisation.
    Moolasart V; Manosuthi W; Ausavapipit J; Chottanapund S; Likanonsakul S; Uttayamakul S; Srisopha S; Lerdsamran H; Puthavathana P
    Int J STD AIDS; 2016 Aug; 27(9):761-8. PubMed ID: 26138900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
    Tsang P; Gorse GJ; Strout CB; Sperling M; Greenberg DP; Ozol-Godfrey A; DiazGranados C; Landolfi V
    Vaccine; 2014 May; 32(21):2507-17. PubMed ID: 24120672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination.
    Cagigi A; Rinaldi S; Di Martino A; Manno EC; Zangari P; Aquilani A; Cotugno N; Nicolosi L; Villani A; Bernardi S; Donatelli I; Pahwa S; Rossi P; Palma P
    J Allergy Clin Immunol; 2014 Feb; 133(2):592-4. PubMed ID: 24290278
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quadrivalent influenza vaccines].
    Wutzler P; Dietz B; Hardt R; Hoins L; Knuf M; Wahle K
    MMW Fortschr Med; 2015 Sep; 157(15):60-2. PubMed ID: 26349732
    [No Abstract]   [Full Text] [Related]  

  • 27. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
    Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
    Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
    J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal trivalent influenza vaccine for 2010-2011.
    Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunogenicity and safety of vaccination against seasonal 2012 influenza virus among patients with psoriatic arthritis and psoriasis.
    Polachek A; Korobko U; Mader-Balakirski N; Arad U; Levartovsky D; Kaufman I; Anouk M; Litinsky I; Wigler I; Mendelson E; Paran D; Matz H; Caspi D; Mandelboim M; Elkayam O
    Clin Exp Rheumatol; 2015; 33(2):181-6. PubMed ID: 25738420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients.
    Fabbiani M; Di Giambenedetto S; Sali M; Farina S; Sansonetti P; Tamburrini E; Dal Verme LZ; Delogu G; De Luca A; Kelvin D; Cauda R; Fadda G
    Vaccine; 2011 Apr; 29(16):2836-9. PubMed ID: 21349364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
    Tremblay CL; Rouleau D; Fortin C; Toma E; Sylla M; Cyr L; Cote S; Baz M; Sampalis J; Trautman L; Sékaly RP; Boivin G
    Vaccine; 2011 Feb; 29(7):1359-63. PubMed ID: 21185423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
    Kositanont U; Assantachai P; Wasi C; Puthavathana P; Praditsuwan R
    Viral Immunol; 2012 Dec; 25(6):471-6. PubMed ID: 23061793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
    Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
    Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.
    Crum-Cianflone NF; Won S; Lee R; Lalani T; Ganesan A; Burgess T; Agan BK
    Vaccine; 2016 Sep; 34(41):5040-5046. PubMed ID: 27577557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.
    Szymczakiewicz-Multanowska A; Groth N; Bugarini R; Lattanzi M; Casula D; Hilbert A; Tsai T; Podda A
    J Infect Dis; 2009 Sep; 200(6):841-8. PubMed ID: 19673651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological response to influenza vaccine after hematopoetic stem cell transplantation.
    Yalçin SS; Kondolot M; Albayrak N; Altaş AB; Karacan Y; Kuşkonmaz B; Aksu S; Cetin M; Göker H; Yurdakök K; Uçkan D
    Ann Hematol; 2010 Sep; 89(9):913-8. PubMed ID: 20119669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.